Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy von Abumiya, Maiko, Takahashi, Naoto, Takahashi, Saori, Yoshioka, Tomoko, Kameoka, Yoshihiro, Miura, Masatomo

Volltext

High baseline total lesion glycolysis predicts early progression of disease within 24 months in patients with high-tumor-burden follicular lymphoma von Kuroki, Wataru, Kitadate, Akihiro, Ishiyama, Koichi, Kameoka, Yoshihiro, Takahashi, Naoto

Volltext

The BCRP inhibitor febuxostat enhances the effect of nilotinib by regulation of intracellular concentration von Ito, Fumiko, Miura, Masatomo, Fujioka, Yuki, Abumiya, Maiko, Kobayashi, Takahiro, Takahashi, Saori, Yoshioka, Tomoko, Kameoka, Yoshihiro, Takahashi, Naoto

Volltext

Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan von Takahashi, Naoto, Nishiwaki, Kaichi, Nakaseko, Chiaki, Aotsuka, Nobuyuki, Sano, Koji, Ohwada, Chikako, Kuroki, Jun, Kimura, Hideo, Tokuhira, Michihide, Mitani, Kinuko, Fujikawa, Kazuhisa, Iwase, Osamu, Ohishi, Kohshi, Kimura, Fumihiko, Fukuda, Tetsuya, Tanosaki, Sakae, Takahashi, Saori, Kameoka, Yoshihiro, Nishikawa, Hiroyoshi, Wakita, Hisashi

Volltext

MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes von Inomata, Mika, Tagawa, Hiroyuki, Guo, Yong-Mei, Kameoka, Yoshihiro, Takahashi, Naoto, Sawada, Kenichi

Volltext

Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia von Takahashi, Naoto, Miura, Masatomo, Scott, Stuart A, Kagaya, Hideaki, Kameoka, Yoshihiro, Tagawa, Hiroyuki, Saitoh, Hirobumi, Fujishima, Naohito, Yoshioka, Tomoko, Hirokawa, Makoto, Sawada, Kenichi

Volltext

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer–cell lymphoma/leukemia von Yamanaka, Yasuo, Tagawa, Hiroyuki, Takahashi, Naoto, Watanabe, Atsushi, Guo, Yong-Mei, Iwamoto, Keiko, Yamashita, Junsuke, Saitoh, Hirobumi, Kameoka, Yoshihiro, Shimizu, Norio, Ichinohasama, Ryo, Sawada, Ken-ichi

Volltext

Relationship between achievement of major molecular response or deep molecular response and nilotinib plasma concentration in patients with chronic myeloid leukemia receiving first... von Fukuda, Natsuki, Akamine, Yumiko, Abumiya, Maiko, Takahashi, Saori, Yoshioka, Tomoko, Kameoka, Yoshihiro, Takahashi, Naoto, Miura, Masatomo

Volltext

Multiparameter Flow Cytometry for the Identification of Neoplastic Plasma Cells in POEMS Syndrome with IgG-kappa Gammopathy: Successful Treatment Using Lenalidomide and Dexamethaso... von Ikeda, Sho, Kobayashi, Takahiro, Saito, Masaya, Komatsuda, Atsushi, Ubukawa, Kumi, Kameoka, Yoshihiro, Takahashi, Naoto

Volltext

Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case C... von Nara, Mizuho, Komatsuda, Atsushi, Itoh, Fumiko, Kaga, Hajime, Saitoh, Masaya, Togashi, Masaru, Kameoka, Yoshihiro, Wakui, Hideki, Takahashi, Naoto

Volltext

Bendamustine plus rituximab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma von Murayama, Kayoko, Kiguchi, Toru, Izutsu, Koji, Kameoka, Yoshihiro, Hidaka, Michihiro, Kato, Harumi, Rai, Shinya, Kuroda, Junya, Ishizawa, Kenichi, Ichikawa, Satoshi, Ando, Kiyoshi, Ogura, Michinori, Fukushima, Koji, Terui, Yasuhito

Volltext

Deep molecular response in patients with chronic phase chronic myeloid leukemia treated with the plasminogen activator inhibitor‐1 inhibitor TM5614 combined with a tyrosine kinase... von Takahashi, Naoto, Kameoka, Yoshihiro, Onizuka, Makoto, Onishi, Yasushi, Takahashi, Fumiaki, Dan, Takashi, Miyata, Toshio, Ando, Kiyoshi, Harigae, Hideo

Volltext

Thrombocytopenia Caused by a Tea Beverage of Taxus yunnanensis (Chinese Yew) von Ubukawa, Kumi, Kameoka, Yoshihiro, Guo, Yong-Mei, Nara, Miho, Watanabe, Atsushi, Fujishima, Masumi, Fujishima, Naohito, Yoshioka, Tomoko, Takahashi, Naoto

Volltext

Safety and efficacy of high-dose ranimustine (MCNU) containing regimen followed by autologous stem cell transplantation for diffuse large B-cell lymphoma von Kameoka, Yoshihiro, Akagi, Tomoaki, Murai, Kazunori, Noji, Hideyoshi, Kato, Yuichi, Sasaki, Osamu, Ito, Shigeki, Ishizawa, Kenichi, Ishida, Yoji, Ichinohasama, Ryo, Harigae, Hideo, Takahashi, Naoto

Volltext

Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL von Onishi, Yasushi, Furukawa, Eijiro, Kamata, Mayumi, Fukatsu, Masahiko, Kameoka, Yoshihiro, Hatta, Shunsuke, Hamada, Hiroyuki, Oyake, Tatsuo, Kai, Tatsuyuki, Sukegawa, Masumi, Nakajima, Shinji, Yanagiya, Ryo, Yamaguchi, Kohei, Takahashi, Taro, Harazaki, Yoriko, Izumi, Toru, Murai, Kazunori, Ito, Shigeki, Ikezoe, Takayuki, Ishizawa, Kenichi, Takahashi, Naoto, Harigae, Hideo

Volltext

Ponatinib Improved the Prognosis of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Japanese Single-Center Cohort Study von Tozawa, Nagi, Yamashita, Takaya, Nara, Miho, Fujioka, Yuki, Ikeda, Sho, Kobayashi, Takahiro, Kobayashi, Isuzu, Kitadate, Akihiro, Kameoka, Yoshihiro, Takahashi, Naoto

Volltext

Relationship between clinical course of nivolumab-related myositis and immune status in a patient with Hodgkin’s lymphoma after allogeneic hematopoietic stem cell transplantation von Kobayashi, Takahiro, Guo, Yong-mei, Yamashita, Takaya, Nara, Miho, Yoshioka, Tomoko, Kameoka, Yoshihiro, Fukuda, Takahiro, Takahashi, Naoto

Volltext

Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia von Mita, Akiko, Abumiya, Maiko, Miura, Masatomo, Niioka, Takenori, Takahashi, Saori, Yoshioka, Tomoko, Kameoka, Yoshihiro, Takahashi, Naoto

Volltext

Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1) von Nakamura, Nobuhiko, Maruyama, Dai, Machida, Ryunosuke, Ichinohe, Tatsuo, Takayama, Nobuyuki, Ohba, Rie, Ohmachi, Ken, Imaizumi, Yoshitaka, Tokunaga, Masahito, Katsuya, Hiroo, Yoshida, Isao, Sunami, Kazutaka, Kurosawa, Mitsutoshi, Kubota, Nobuko, Morimoto, Hiroaki, Kobayashi, Miki, Kato, Harumi, Kameoka, Yoshihiro, Kagami, Yoshitoyo, Kizaki, Masahiro, Takeuchi, Kazuto, Munakata, Wataru, Iida, Shinsuke, Nagai, Hirokazu

Volltext

Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin’s lymphoma von Oyake, Tatsuo, Maeta, Takahiro, Takahata, Takenori, Tamai, Yoshiko, Kameoka, Yoshihiro, Takahashi, Naoto, Miyairi, Yasuro, Murai, Kazunori, Shimosegawa, Kenji, Yoshida, Kozue, Inokura, Kyoko, Fukuhara, Noriko, Harigae, Hideo, Sato, Ryo, Ishizawa, Kenichi, Tajima, Katsushi, Saitou, Souichi, Fukatsu, Masahiko, Ikezoe, Takayuki, Tsunoda, Saburo, Mita, Masayuki, Mori, Jinichi, Kowata, Shugo, Ito, Shigeki

Volltext